New biomarker test could spare patients unnecessary lung biopsies
NCT ID NCT01085864
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks for markers in blood, sputum, or urine that can help doctors decide if a lung nodule found on a CT scan is cancerous or harmless. The goal is to reduce the need for invasive biopsies. Researchers will also check if these markers return to normal after successful cancer surgery.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG ABSCESS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Colorado Anschutz Medical Campus
Aurora, Colorado, 80045, United States